Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia

Abstract Background The main advantage of GeneXpert MTB/RIF® (Xpert) molecular diagnostic technology is the rapid detection of M.tuberculosis DNA and mutations associated with rifampicin (RIF) resistance for timely initiation of appropriate treatment and, consequently, preventing further transmissio...

Description complète

Détails bibliographiques

Auteurs principaux:	Julia V. Ershova, Grigory V. Volchenkov, Tatiana R. Somova, Tatiana A. Kuznetsova, Natalia V. Kaunetis, Dorothy Kaminski, Olga V. Demikhova, Larisa N. Chernousova, Irina A. Vasilyeva, Eleanor M. Kerr, J. Peter Cegielski, Ekaterina V. Kurbatova
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2020-07-01
Collection:	BMC Infectious Diseases
Sujets:	Drug resistance Rifampicin GeneXpert MTB/RIF
Accès en ligne:	http://link.springer.com/article/10.1186/s12879-020-05243-9
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!